Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin C in Post-cardiac Arrest Shock
NCT05817851Phase 2Terminated
- Sponsor
- Centre Hospitalier de Béthune-Beuvry
- Start
- Dec 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ascorbic acid in cardiac arrest (SCA) (2 arms), sponsored by Centre Hospitalier de Béthune-Beuvry. Primary endpoint: Cumulative incidence of weaning from vasopressors at 3 days. Started Dec 2023; status: terminated.
02
Drugs
ascorbic acid
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05817851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05817851.